CMS Obliterates Medicaid Managed Care Loophole with Draconian Medicare-Pegged Payment Caps

Once the federal government provides its matching funds, the entire inflated pool of capital is routed directly back to the contributing providers under the guise of uniform payment increases. The Centers for Medicare and Medicaid Services has recognized that this cyclical self-dealing absolves states of their statutory burden to share in the financing of Medicaid and incentivizes rampant program waste. Projected State Directed Payment spending was on track to reach an astronomical $246 billion by fiscal year 2034 if left unchecked. This sweeping regulatory overhaul, catalyzed by the recently enacted Working Families Tax Cut legislation and a June 2025 Presidential Memorandum, permanently severs the link between Average Commercial Rates and Medicaid managed care payments. The Working Families Tax Cut legislation was enacted on July 4, 2025, directly following the June 6, 2025 Presidential Memorandum that directed the Secretary of Health and Human Services to eliminate fraud, waste, and abuse. The Department of Health and Human Services is imposing a hard, inescapable ceiling on what providers can extract from the system. The sudden removal of Average Commercial Rate ceilings will strip an estimated $70 billion in projected revenue from the hospital sector over the next decade, fundamentally disrupting the cash flow of highly leveraged regional health systems (Smith). For states that have adopted Medicaid expansion, the total payment rate for services covered under a State Directed Payment is now strictly capped at one hundred percent of the total published Medicare payment rate. States that have rejected Medicaid expansion are granted a slightly higher, but equally rigid, cap set at one hundred and ten percent of the published Medicare payment rate. In instances where a specific Medicaid service lacks a corresponding published Medicare rate, the payment limit defaults unequivocally to one hundred percent of the approved Medicaid State plan rate. This cap fundamentally rewrites the economic reality for thousands of healthcare facilities that have grown dependent on artificially inflated commercial-equivalent reimbursement rates. Municipal bond markets are already beginning to reprice the debt of major academic medical centers and safety-net hospitals, pricing in a higher risk of default as these institutions lose access to this critical federal subsidy stream (Fitch Ratings). The new payment limits will be calculated at a service or discharge-specific level rather than an aggregate level, utilizing tools like the published Medicare fee schedules to mandate strict per-service compliance. The rule initially targets the four largest drivers of State Directed Payment spending, specifically inpatient hospital services, outpatient hospital services, nursing facility services, and qualified practitioner services at academic medical centers. For these four core services, the severe new payment limits become applicable for any rating period beginning on or after July 4, 2025. The federal government is not stopping at the statutory mandate. Using its sweeping authority to ensure actuarially sound capitation rates, the agency is unilaterally extending this stringent payment ceiling to all State Directed Payments, across all services, and encompassing the United States territories. This universal application will take effect for rating periods beginning on or after January 1, 2029, leaving no corner of the managed care ecosystem exempt from the new financial guardrails. Beginning with rating periods starting on or after July 9, 2026, states are also required to comply with prospective submission rules, forcing them to submit all State Directed Payment preprints before the start date of the applicable arrangement. To prevent states from simply shifting their financial engineering from the managed care sector back to the traditional fee-for-service system, the rule constructs a parallel barrier. Targeted fee-for-service supplemental payments made to specific practitioners and providers are now bound by the exact same Medicare-equivalent upper payment limits. This parallel barrier applies a practitioner-or provider-specific limit to payments targeted at subsets of providers, encompassing physicians, dentists, ground emergency medical transportation, air ambulance, and non-emergency medical transportation providers. Unlike historical Upper Payment Limits that were applied on an aggregate class basis, this fee-for-service targeted limit applies directly to individual practitioner and provider total payments. Private equity sponsors heavily invested in hospital-based physician staffing models, such as emergency medicine and anesthesiology, will experience immediate margin compression as these fee-for-service practitioner payment caps neutralize their previously successful revenue maximization strategies (Jones). States attempting to maintain their exorbitant fee-for-service practitioner payments must submit a State plan amendment to bring their methodologies into compliance no later than the start of the first state fiscal year beginning on or after January 1, 2029. There are only narrow exceptions to this targeted fee-for-service limit, specifically when there is no reasonable Medicare equivalent payment rate or when payments are explicitly reconciled to a practitioner's actual incurred costs. The architecture of this rule systematically hunts down and neutralizes the specific mechanisms states have used to game the system. The most profound operational trap buried within this text is the total prohibition of uniform increase State Directed Payments. Historically, states have utilized uniform dollar or percentage increases to guarantee that a pre-determined, fixed pool of tax or transfer money is fully exhausted and returned to the contributing providers. When actual patient utilization fell short of projections, states would simply amend the State Directed Payment retroactively, arbitrarily increasing the per-service payment amount to ensure the providers still received their guaranteed windfall. The agency has identified this practice as fundamentally incompatible with risk-based managed care. Beginning with the first rating period on or after January 1, 2028, states are entirely forbidden from implementing new or renewing non-grandfathered uniform increase State Directed Payments. States are now restricted to implementing minimum or maximum fee schedules, fundamentally shifting the risk back to the providers and ensuring that aggregate payments are strictly tethered to actual medical services rendered. There is a narrow, heavily policed safe harbor for existing financial arrangements, explicitly defined as the temporary grandfathering period. To qualify as a grandfathered State Directed Payment, the arrangement must exclusively cover one of the four heavily regulated service types and must have either received written prior approval or had a completed preprint submitted to the agency before July 4, 2025. Crucially, the rating period for these grandfathered arrangements must include at least one business day within a strictly defined window surrounding the enactment of the Working Families Tax Cut legislation, specifically between October 11, 2024 and March 27, 2026. More precisely, the rule requires the rating period to include at least one business day either between October 11, 2024 and July 3, 2025, or between July 5, 2025 and March 27, 2026. For those few arrangements that manage to navigate this incredibly tight eligibility gauntlet, the reprieve is explicitly temporary and structurally designed to force compliance. The maximum permissible expenditure for any grandfathered State Directed Payment is forever locked to the total dollar amount explicitly documented in item four of the approved preprint. States are strictly prohibited from modifying these grandfathered preprints to increase the total dollar amount or alter the rating period to manufacture eligibility. Beginning with the first rating period on or after January 1, 2028, these grandfathered total dollar amounts must be aggressively phased down. States are mandated to reduce the total allowed expenditure by a minimum of ten percentage points annually, calculated against the original baseline grandfathered amount, until the payment rate aligns with the new Medicare-based limits. This aggressive phase-down will likely catalyze a wave of distressed mergers and acquisitions, as undercapitalized independent hospitals are forced to seek acquisition by well-capitalized national chains simply to survive the revenue contraction (Miller). To monitor this phase-down process, beginning with the first rating period on or after January 1, 2027, states must annually submit a total payment rate comparison certified by an actuary. During this phase-down period, states are granted a rare, time-limited exemption from the standard prohibition against separate payment terms. This temporary allowance is not a concession, but rather a mechanism to ensure the federal government can easily isolate, monitor, and audit the precise reduction of the fixed funding pool. The moment the grandfathered State Directed Payment reaches the statutory payment limit, the exemption evaporates, and the state must immediately integrate the payment back into the base capitation rates and comply with the ban on uniform increases. The rule also detonates hidden compliance landmines for specific subsets of the healthcare industry. Hospitals that do not rely on prospectively published Medicare rates, such as Critical Access Hospitals, certain cancer treatment centers, and freestanding children's hospitals, are uniquely exposed. Because these facilities are reimbursed by Medicare on a retrospective cost basis, there is no published rate to serve as an easy benchmark. The agency will now require the most recent and complete Medicare cost report to establish a prospective, per-service payment limit, forcing states to execute highly complex cost allocation methodologies just to prove compliance. States attempting to pivot toward Value-Based Purchasing State Directed Payments to evade the new fee schedule mandates face an immense operational hurdle. If a state implements a population-based or condition-based payment model, it must simultaneously submit a detailed, rigorous validation methodology proving that the prospective per-member payments do not exceed the per-service payment limit when reconciled against actual utilization. This reconciliation requirement transforms value-based payments from a flexible financing tool into an administrative auditing nightmare. State governments face an imminent budget crisis, as the loss of artificially inflated federal matching funds will require them to dramatically increase appropriations from their own general funds just to maintain current Medicaid service levels, potentially crowding out infrastructure and education spending (Chen). To further enforce these caps, states must submit a list of all providers eligible for the State Directed Payment and their National Provider Identifiers, which will allow the government to extract Transformed Medicaid Statistical Information System data to independently verify adherence to the payment limits. The federal government is also aggressively cracking down on secondary mandates and third-party skimming. The text explicitly outlaws the practice of conditioning a provider's receipt of State Directed Payment funds on the requirement that the provider kick back a portion of the money to private consultants, provider associations, or the managed care plans themselves. Payments must be based exclusively on the utilization and delivery of actual medical services. Vague contractual requirements, frequently referred to as grey area payments, where states force actuaries to assume inflated payment rates without formally submitting a State Directed Payment preprint, are completely outlawed. This specifically targets the impermissible practice of legislatures appropriating funds for enhanced provider rates and forcing actuaries to include those appropriations as a rate development assumption outside the required preprint approval framework. States are also strictly forbidden from substituting incentive arrangements or withhold arrangements, which are payments to managed care plans, as unauthorized vehicles to direct provider payments. The agency is signaling a zero-tolerance policy for any contractual language that dictates managed care expenditures outside of the rigid, heavily monitored State Directed Payment approval framework. Even the definition of a provider class is under extreme scrutiny. The agency is actively targeting states that artificially define a provider class to encompass a single hospital solely to channel intergovernmental transfers back to that specific entity. While the rule stops short of immediately mandating that State Directed Payment provider classes perfectly mirror State plan definitions, the threat of future enforcement is unequivocally stated. The regulatory environment for Medicaid financing has been permanently and fundamentally altered. The era of states using federal matching funds to operate risk-free financial enrichment programs for select institutional providers has officially ended. Every state legislature, Medicaid director, and hospital administrator must immediately begin dismantling their uniform increase structures and preparing for the severe financial contraction mandated by the January 2028 phase-down.